These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32839684)

  • 1. Cross-sectional Study on the Impact of Discount Pricing and Price Competition on Community Pharmacy Practice.
    Mathews A; Ming LC; Che Rose FZ; Abbas SA
    Cureus; 2020 Aug; 12(8):e9903. PubMed ID: 32839684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring strategies to overcome extra-organisational challenges faced by community pharmacies in Sarawak, Malaysia.
    Kho BP; Hassali MA; Lim CJ; Saleem F
    Int J Pharm Pract; 2018 Dec; 26(6):494-500. PubMed ID: 29542834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacists' views and reported practices in relation to a new generic drug substitution policy in Lebanon: a mixed methods study.
    El-Jardali F; Fadlallah R; Morsi RZ; Hemadi N; Al-Gibbawi M; Haj M; Khalil S; Saklawi Y; Jamal D; Akl EA
    Implement Sci; 2017 Feb; 12(1):23. PubMed ID: 28212657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do higher-priced generic medicines enjoy a competitive advantage under reference pricing?
    Puig-Junoy J
    Appl Health Econ Health Policy; 2012 Nov; 10(6):441-51. PubMed ID: 22900924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary health care pharmacists and vision for community pharmacy and pharmacists in Chile.
    Martínez-Mardones F; Ahumada-Canale A; Gonzalez-Machuca L; Plaza-Plaza JC
    Pharm Pract (Granada); 2020; 18(3):2142. PubMed ID: 32922575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A national survey exploring oral healthcare service provision across Australian community pharmacies.
    Freeman CR; Abdullah N; Ford PJ; Taing MW
    BMJ Open; 2017 Sep; 7(9):e017940. PubMed ID: 28963314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Community pharmacy in the United Arab Emirates: characteristics and workforce issues.
    Hasan S; Sulieman H; Chapman C; Stewart K; Kong DC
    Int J Pharm Pract; 2011 Dec; 19(6):392-9. PubMed ID: 22060234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacists' adoption into practice of newly reclassified medicines from diverse therapeutic areas in Scotland: a quantitative study of factors associated with decision-making.
    Paudyal V; Hansford D; Cunningham S; Stewart D
    Res Social Adm Pharm; 2014; 10(1):88-105. PubMed ID: 23665077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The corporatization of community pharmacy: implications for service provision, the public health function, and pharmacy's claims to professional status in the United Kingdom.
    Bush J; Langley CA; Wilson KA
    Res Social Adm Pharm; 2009 Dec; 5(4):305-18. PubMed ID: 19962674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaceutical counseling: Between evidence-based medicine and profits.
    Egorova SN; Akhmetova T
    Int J Risk Saf Med; 2015; 27 Suppl 1():S87-8. PubMed ID: 26639727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Community pharmacists' opinions and practice of pharmaceutical care at chain pharmacy and independent pharmacy in China.
    Xi X; Huang Y; Lu Q; Ung COL; Hu H
    Int J Clin Pharm; 2019 Apr; 41(2):478-487. PubMed ID: 30864081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knowledge, attitude, and practice of pharmacy professionals on generic medicines in Eastern Ethiopia: A cross-sectional study.
    Mohammed AS; Woldekidan NA; Mohammed FA
    PLoS One; 2020; 15(7):e0235205. PubMed ID: 32658918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of unmet demand for pharmacists: a survey of rural community pharmacies in Wisconsin.
    Gadkari AS; Mott DA; Kreling DH; Bonnarens JK
    J Am Pharm Assoc (2003); 2008; 48(5):598-609. PubMed ID: 18826899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Community pharmacy practice in Japan--results of a survey.
    Iguchi S; Ohnishi M; Nishiyama T; Hosono K; Umezawa C
    J Clin Pharm Ther; 1998 Jun; 23(3):223-7. PubMed ID: 9831974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generic Medicine Pricing Policies in Europe: Current Status and Impact.
    Dylst P; Simoens S
    Pharmaceuticals (Basel); 2010 Mar; 3(3):471-481. PubMed ID: 27713264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Examination of why some community pharmacists do not provide 72-hour emergency prescription drugs to Medicaid patients when prior authorization is not available.
    Shepherd MD
    J Manag Care Pharm; 2013 Sep; 19(7):523-33. PubMed ID: 23964613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What role could community pharmacists in Malaysia play in diabetes self-management education and support? The views of individuals with type 2 diabetes.
    Lee EL; Wong PS; Tan MY; Sheridan J
    Int J Pharm Pract; 2018 Apr; 26(2):138-147. PubMed ID: 28574154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variation of prescription drug prices in community pharmacies: A national cross-sectional study.
    Larkin J; Moriarty F; McGuinness S; Finucane K; Fitzgerald K; Smith SM; O'Mahony JF
    Res Social Adm Pharm; 2022 Oct; 18(10):3736-3743. PubMed ID: 35618647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discounting of medicines in Australian community pharmacies.
    Thai LP; Vitry AI; Moss JR
    Aust Health Rev; 2014 Nov; 38(5):517-22. PubMed ID: 25099433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi stakeholders of health and industries perspectives on medicine price transparency initiative in private health care settings in Malaysia.
    Sufiza Ahmad N; Makmor-Bakry M; Hatah E
    Saudi Pharm J; 2020 Jul; 28(7):850-858. PubMed ID: 32647487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.